201 related articles for article (PubMed ID: 10593363)
1. Aromatase: a key molecule in the pathophysiology of endometriosis and a therapeutic target.
Zeitoun KM; Bulun SE
Fertil Steril; 1999 Dec; 72(6):961-9. PubMed ID: 10593363
[TBL] [Abstract][Full Text] [Related]
2. Estrogen production in endometriosis and use of aromatase inhibitors to treat endometriosis.
Bulun SE; Zeitoun K; Takayama K; Noble L; Michael D; Simpson E; Johns A; Putman M; Sasano H
Endocr Relat Cancer; 1999 Jun; 6(2):293-301. PubMed ID: 10731122
[TBL] [Abstract][Full Text] [Related]
3. Role of aromatase in endometrial disease.
Bulun SE; Yang S; Fang Z; Gurates B; Tamura M; Zhou J; Sebastian S
J Steroid Biochem Mol Biol; 2001 Dec; 79(1-5):19-25. PubMed ID: 11850203
[TBL] [Abstract][Full Text] [Related]
4. Estrogen production and metabolism in endometriosis.
Bulun SE; Yang S; Fang Z; Gurates B; Tamura M; Sebastian S
Ann N Y Acad Sci; 2002 Mar; 955():75-85; discussion 86-8, 396-406. PubMed ID: 11949967
[TBL] [Abstract][Full Text] [Related]
5. Stimulation of aromatase P450 promoter (II) activity in endometriosis and its inhibition in endometrium are regulated by competitive binding of steroidogenic factor-1 and chicken ovalbumin upstream promoter transcription factor to the same cis-acting element.
Zeitoun K; Takayama K; Michael MD; Bulun SE
Mol Endocrinol; 1999 Feb; 13(2):239-53. PubMed ID: 9973254
[TBL] [Abstract][Full Text] [Related]
6. Estrogen biosynthesis in endometriosis: molecular basis and clinical relevance.
Bulun SE; Zeitoun KM; Takayama K; Sasano H
J Mol Endocrinol; 2000 Aug; 25(1):35-42. PubMed ID: 10915216
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of excessive estrogen formation in endometriosis.
Bulun SE; Gurates B; Fang Z; Tamura M; Sebastian S; Zhou J; Amin S; Yang S
J Reprod Immunol; 2002; 55(1-2):21-33. PubMed ID: 12062819
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin E2 stimulates aromatase expression in endometriosis-derived stromal cells.
Noble LS; Takayama K; Zeitoun KM; Putman JM; Johns DA; Hinshelwood MM; Agarwal VR; Zhao Y; Carr BR; Bulun SE
J Clin Endocrinol Metab; 1997 Feb; 82(2):600-6. PubMed ID: 9024261
[TBL] [Abstract][Full Text] [Related]
9. Aromatase as a therapeutic target in endometriosis.
Bulun SE; Zeitoun KM; Takayama K; Simpson E; Sasano H
Trends Endocrinol Metab; 2000; 11(1):22-7. PubMed ID: 10652502
[TBL] [Abstract][Full Text] [Related]
10. Analysis of aromatase and 17beta-hydroxysteroid dehydrogenase type 2 messenger ribonucleic acid expression in deep endometriosis and eutopic endometrium using laser capture microdissection.
Matsuzaki S; Canis M; Pouly JL; Déchelotte PJ; Mage G
Fertil Steril; 2006 Feb; 85(2):308-13. PubMed ID: 16595205
[TBL] [Abstract][Full Text] [Related]
11. [Aromatase inhibitors--theoretical concept and present experiences in the treatment of endometriosis].
Ebert AD; Bartley J; David M; Schweppe KW
Zentralbl Gynakol; 2003; 125(7-8):247-51. PubMed ID: 14505258
[TBL] [Abstract][Full Text] [Related]
12. Aromatase and endometriosis.
Bulun SE; Fang Z; Imir G; Gurates B; Tamura M; Yilmaz B; Langoi D; Amin S; Yang S; Deb S
Semin Reprod Med; 2004 Feb; 22(1):45-50. PubMed ID: 15083380
[TBL] [Abstract][Full Text] [Related]
13. WT1 and DAX-1 inhibit aromatase P450 expression in human endometrial and endometriotic stromal cells.
Gurates B; Sebastian S; Yang S; Zhou J; Tamura M; Fang Z; Suzuki T; Sasano H; Bulun SE
J Clin Endocrinol Metab; 2002 Sep; 87(9):4369-77. PubMed ID: 12213901
[TBL] [Abstract][Full Text] [Related]
14. Molecular basis for treating endometriosis with aromatase inhibitors.
Bulun SE; Zeitoun KM; Takayama K; Sasano H
Hum Reprod Update; 2000; 6(5):413-8. PubMed ID: 11045871
[TBL] [Abstract][Full Text] [Related]
15. Deficient 17beta-hydroxysteroid dehydrogenase type 2 expression in endometriosis: failure to metabolize 17beta-estradiol.
Zeitoun K; Takayama K; Sasano H; Suzuki T; Moghrabi N; Andersson S; Johns A; Meng L; Putman M; Carr B; Bulun SE
J Clin Endocrinol Metab; 1998 Dec; 83(12):4474-80. PubMed ID: 9851796
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandin E2 via steroidogenic factor-1 coordinately regulates transcription of steroidogenic genes necessary for estrogen synthesis in endometriosis.
Attar E; Tokunaga H; Imir G; Yilmaz MB; Redwine D; Putman M; Gurates B; Attar R; Yaegashi N; Hales DB; Bulun SE
J Clin Endocrinol Metab; 2009 Feb; 94(2):623-31. PubMed ID: 19001523
[TBL] [Abstract][Full Text] [Related]
17. Regulation of aromatase P450 expression in endometriotic and endometrial stromal cells by CCAAT/enhancer binding proteins (C/EBPs): decreased C/EBPbeta in endometriosis is associated with overexpression of aromatase.
Yang S; Fang Z; Suzuki T; Sasano H; Zhou J; Gurates B; Tamura M; Ferrer K; Bulun S
J Clin Endocrinol Metab; 2002 May; 87(5):2336-45. PubMed ID: 11994385
[TBL] [Abstract][Full Text] [Related]
18. C-Jun NH2-Terminal Kinase and p38 Inhibition Suppresses Prostaglandin E2-Stimulated Aromatase and Estrogen Receptor Levels in Human Endometriosis.
Zeng C; Xu JN; Zhou Y; Yang HX; Zhou YF; Xue Q
J Clin Endocrinol Metab; 2015 Nov; 100(11):E1404-14. PubMed ID: 26394174
[TBL] [Abstract][Full Text] [Related]
19. Aromatase inhibitors and cyclooxygenase-2 (COX-2) inhibitors in endometriosis: new questions--old answers?
Ebert AD; Bartley J; David M
Eur J Obstet Gynecol Reprod Biol; 2005 Oct; 122(2):144-50. PubMed ID: 16157442
[TBL] [Abstract][Full Text] [Related]
20. Aromatase and other steroidogenic genes in endometriosis: translational aspects.
Attar E; Bulun SE
Hum Reprod Update; 2006; 12(1):49-56. PubMed ID: 16123052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]